- Home
- LKCO vs APVO Comparison
LKCO vs APVO Comparison
Compare LKCO & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKCO
- APVO
- Stock Information
- Founded
- LKCO 2009
- APVO 2016
- Country
- LKCO China
- APVO United States
- Employees
- LKCO N/A
- APVO N/A
- Industry
- LKCO EDP Services
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- LKCO Technology
- APVO Health Care
- Exchange
- LKCO Nasdaq
- APVO Nasdaq
- Market Cap
- LKCO 5.5M
- APVO 6.5M
- IPO Year
- LKCO N/A
- APVO N/A
- Fundamental
- Price
- LKCO $1.69
- APVO $4.46
- Analyst Decision
- LKCO
- APVO Strong Buy
- Analyst Count
- LKCO 0
- APVO 1
- Target Price
- LKCO N/A
- APVO $296.00
- AVG Volume (30 Days)
- LKCO 187.4K
- APVO 90.6K
- Earning Date
- LKCO 10-22-2024
- APVO 03-04-2025
- Dividend Yield
- LKCO N/A
- APVO N/A
- EPS Growth
- LKCO N/A
- APVO N/A
- EPS
- LKCO N/A
- APVO N/A
- Revenue
- LKCO $5,389,818.00
- APVO N/A
- Revenue This Year
- LKCO N/A
- APVO N/A
- Revenue Next Year
- LKCO N/A
- APVO N/A
- P/E Ratio
- LKCO N/A
- APVO N/A
- Revenue Growth
- LKCO N/A
- APVO N/A
- 52 Week Low
- LKCO $1.43
- APVO $3.65
- 52 Week High
- LKCO $8.00
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- LKCO 43.31
- APVO 38.21
- Support Level
- LKCO $1.90
- APVO $4.32
- Resistance Level
- LKCO $2.15
- APVO $4.79
- Average True Range (ATR)
- LKCO 0.26
- APVO 0.45
- MACD
- LKCO -0.03
- APVO 0.15
- Stochastic Oscillator
- LKCO 6.67
- APVO 19.53
About LKCO Luokung Technology Corp
Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.